Cargando…
Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer
To test the hypothesis that concomitant targeting of the epidermal growth factor receptor (EGFR) and transforming growth factor-beta (TGF-β) may offer a novel therapeutic approach in pancreatic cancer, EGFR silencing by RNA interference (shEGFR) was combined with TGF-β sequestration by soluble TGF-β...
Autores principales: | Deharvengt, Sophie, Marmarelis, Melina, Korc, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384603/ https://www.ncbi.nlm.nih.gov/pubmed/22761868 http://dx.doi.org/10.1371/journal.pone.0039684 |
Ejemplares similares
-
Retraction: Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer
Publicado: (2020) -
Intra-Tumoral Delivery of shRNA Targeting Cyclin D1 Attenuates Pancreatic Cancer Growth
por: Deharvengt, Sophie J., et al.
Publicado: (2009) -
Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes
por: Craven, Kelly E., et al.
Publicado: (2015) -
microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions
por: Ouyang, H, et al.
Publicado: (2014) -
Erratum: microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions
por: Ouyang, H, et al.
Publicado: (2017)